Next Article in Journal
Fast Chromatographic Method for Explosive Profiling
Next Article in Special Issue
In Situ Measurement of Polymer Layer Thickness in Porous Layer Open Tubular (PLOT) Columns Using Optical Absorbance in the Near-IR Range
Previous Article in Journal
Effects of Different Levels of Echinostoma caproni Miracidial Dose on Glucose and Maltose Composition of Biomphalaria glabrata Snails as Determined by High Performance Thin-Layer Chromatography-Densitometry
Previous Article in Special Issue
Recent Advances and Uses of Monolithic Columns for the Analysis of Residues and Contaminants in Food
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Chromatography
Volume 2
Issue 2
10.3390/chromatography2020195
chromatography-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Please note that, as of 1 January 2016, Chromatography has been renamed to Separations and is now published here.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Monoliths in Bioprocess Technology

by
Vignesh Rajamanickam
1,2,
Christoph Herwig
1,2 and
Oliver Spadiut
1,2,*
1
Research Division Biochemical Engineering, Institute of Chemical Engineering, Vienna University of Technology, Gumpendorfer Strasse 1A/166-4, 1060 Vienna, Austria
2
Christian Doppler Laboratory for Mechanistic and Physiological Methods for Improved Bioprocesses, Institute of Chemical Engineering, Vienna University of Technology, Getreidemarkt 9/166, A-1060 Vienna, Austria
*
Author to whom correspondence should be addressed.
Chromatography 2015, 2(2), 195-212; https://doi.org/10.3390/chromatography2020195
Submission received: 6 February 2015 / Revised: 8 April 2015 / Accepted: 14 April 2015 / Published: 17 April 2015
(This article belongs to the Special Issue Monolithic Columns in Separation Sciences)
Browse Figures
Versions Notes

Abstract

:
Monolithic columns are a special type of chromatography column, which can be used for the purification of different biomolecules. They have become popular due to their high mass transfer properties and short purification times. Several articles have already discussed monolith manufacturing, as well as monolith characteristics. In contrast, this review focuses on the applied aspect of monoliths and discusses the most relevant biomolecules that can be successfully purified by them. We describe success stories for viruses, nucleic acids and proteins and compare them to conventional purification methods. Furthermore, the advantages of monolithic columns over particle-based resins, as well as the limitations of monoliths are discussed. With a compilation of commercially available monolithic columns, this review aims at serving as a ‘yellow pages’ for bioprocess engineers who face the challenge of purifying a certain biomolecule using monoliths.

1. Introduction

The Centre for Chemical Process Safety (CCPS) defines a bioprocess as a process that makes use of microorganisms, cell culture or enzymes to manufacture a product or to complete a chemical transformation [1]. In other words, a bioprocess envelops production and purification of a biomolecule that can be of therapeutic (e.g., protein-based therapeutic drugs) or economic importance (e.g., food industry, waste water treatment). As shown in Figure 1, a typical bioprocess is comprised of upstream (strain engineering, production of target biomolecule) and downstream processes (clarification, separation, purification). In a typical downstream process, the product undergoes capture, purification and/or polishing steps to yield the final, purified preparation. Of course, these steps and their execution depend on the purity of the starting material; e.g., the purification of an intracellular biomolecule from E. coli might require more purification steps than the purification of a secreted product from yeast. During the last decade, production titers in the upstream dramatically increased due to strain engineering, media optimization and bioprocess engineering approaches. However, the downstream process did not develop at the same pace, which is why product purification actually describes the bottleneck of a typical bioprocess. To date, conventional downstream methods, like centrifugation and filtration, are not able to handle the high product titers coming from the upstream process [2], which is why alternative, fast and efficient separation techniques are needed. Chromatography with particle-based resins has become the backbone of downstream processing for biomolecules, such as viruses, nucleic acids and proteins. However, mass transfer in particle-based resins occurs through diffusion, which is why purification of large biomolecules, such as glyco-proteins and immunoglobulins, takes a long time. This can be critical for unstable products, which is why faster purification methods are needed. In the past twenty years, monolithic columns have become popular as an efficient tool for the purification of large biomolecules due to their high mass transfer properties and short purification times [3]. Monoliths are a special type of chromatographic column having a single block of a homogenous stationary phase with many interconnected channels [4]. The stationary phase of the monolith can be of various chemistries, allowing the purification of different kinds of biomolecules with different characteristics. Monoliths are the fourth generation chromatography material [3], succeeding beads, porous particle-based columns and membrane adsorbers. In the last two decades, numerous articles describing preparation, properties and applications of monolithic columns were published [4,5,6,7,8,9,10,11,12,13,14,15,16,17,18]. In contrast, this review focuses on the applied aspect of monoliths and describes recent applications of monoliths for the purification of biomolecules. Thus, this review serves as a ‘yellow pages’ for bioprocess engineers who want to purify a certain biomolecule by monoliths.

2. Advantages and Limitations of Monoliths

The complexity of any purification process is finding the optimal balance between surface area, porosity, pore size and distribution and other physical and chemical properties of the chromatographic support, such as mass transfer properties and flow distribution. In this respect, monoliths show several advantages over particle-based resins.
Chromatography 02 00195 g001 1024
Figure 1. Schematic diagram of a typical bioprocess. (A) different downstream unit operations, (B) convective interaction media (CIM®) monolithic column [19].
Figure 1. Schematic diagram of a typical bioprocess. (A) different downstream unit operations, (B) convective interaction media (CIM®) monolithic column [19].
Chromatography 02 00195 g001

2.1. Advantages of Monolithic Columns

2.1.1. Convective Flow

In particle-based resins, separation processes happen by diffusion into pores. The longitudinal diffusion of the target analyte declines with increasing flow rate. Furthermore, the diffusion coefficient, which is comprised of both diffusive and convective components, is predominantly dependent on convection for higher flow velocities, which, in turn, is dependent on the pore size [20]. In contrast to particle-based resins, in monoliths, the separation of biomolecules dominantly happens by convective flow through channels having a diameter of more than 1,000 nm. This allows high flow velocity and, therefore, high throughput purifications [16].

2.1.2. Porosity

Monolithic columns have high porosity due to their large interconnected channels. Optimization of pore size and pore distribution can be done over a wide range by changing the porogen composition, porogen to monomer ratio and polymerization temperature [21,22,23,24,25]. Owing to their high bed porosity, the pressure drop in monoliths is much lower in comparison to particle-based resins.

2.1.3. Adsorption Area and Dynamic Binding Capacity

Monolithic columns have a low absolute surface area, but a high adsorption area due to their porous structure [3], allowing a high dynamic binding capacity (DBC). Another main advantage of monoliths is their flow-independent DBC allowing straight-forward scalability [3,26,27,28]. A direct comparison between monoliths and particle-based resins for the purification of virus-like particles from yeast homogenate has been conducted by Burden et al. The authors concluded that the monoliths are three-fold superior in terms of DBC with equivalent recovery in yield (90%) compared to particle-based resins [29].

2.1.4. Separation Time

Due to the high flow velocity and low pressure drop, the overall process time using monoliths is much lower compared to particle-based resins [30]. For example, Rupar et al. were able to purify potato virus Y with the help of monolithic columns in half the separation time in comparison to classical methods. Even though the yield achieved by monolithic columns was slightly lower than by classical methods, the possibility for easy scale-up offered valuable compensation for subsequent industrial-scale purification [31]. In another study, a direct performance comparison between conventional and monolithic C-18 columns was conducted, and it was shown that separation time was decreased five-fold by using monolithic columns [32].

2.1.5. Stationary Phase

Monoliths allow a high degree of freedom for the operator, since they can be manufactured from various raw materials (such as polymethacrylate, polyacrylamide, polystyrene, silica and cryogels) with different morphologies and channel diameters [33]. In general, the monolithic media can be classified into two categories, namely organic, polymer-based and inorganic, silica-based media. The main advantages of organic, polymer-based media are pH stability and customizability, but the columns are mechanically not very stable, which shortens the column life-time. On the other hand, inorganic, silica-based monoliths show excellent stability and separation efficiency. However, manufacturing is sophisticated and time consuming [34]. Recently, also organic-inorganic hybrid monoliths have been prepared combining the advantages of both [34,35,36].

2.1.6. Customizability

Monoliths can be customized to the needs of the user, since there are various stationary phase chemistries, active binding sites and shapes and sizes (disks, tubes) available. Although the shape of the monolith per se does not present a significant advantage, a minor advantage to be noted is that monolithic disks (0.34 mL) do not have a specific flow direction, enabling back-flush to encounter clogging problems. BIA separations, Slovenia, offers small 0.34-mL monolithic disk columns comprising a wide variety of stationary phases [19]. Since monolithic columns do not lose resolution with scale-up, preliminary, less expensive characterization and screening studies using analytical-scale disks are possible.

2.1.7. Scalability

Monolithic supports are easy to scale up without the need for column modifications [3,26]. Monolithic disks can be stacked up to four disks in the same housing, increasing efficiency and capacity without compromising resolution [3]. Monoliths have overcome the mass transfer problems posed by particle-based columns, and commercial monolithic columns up to 8 L are available [3].

2.2. Limitations of Monolithic Columns

Mass transfer in monoliths is based on convection and, hence, cannot be used for size exclusion chromatography (SEC), since SEC is based on the difference in diffusivity of individual molecules into pores. Recently, it was shown that biomolecules can still be separated by size by using friction in the monolithic support, called slalom chromatography [37,38,39]. However, monolithic columns for slalom chromatography have to be further optimized and have not been utilized in industry yet [3].
Fouling and clogging is another major limitation in most chromatographic columns, as it results in the reduction of DBC and an increase in the pressure drop across the column, which decreases the life span of the column significantly. As mentioned before, back-flush is possible only in smaller monolithic disks (with axial flow) to reverse fouling and clogging and is not possible in tubular monolithic columns (with radial flow).
Lipids are a major class of biological foulants, as they bind irreversibly and are hard to remove from the column. Burden et al. tackled lipid fouling by sample pretreatment, using Amberlite/XAD-4 beads for lipid removal, which doubled the dynamic binding capacity of a monolithic disk column [29].

3. Applications of Monoliths

Monolithic supports have been extensively used for the purification of different biomolecules. Boehringer Ingelheim (Austria) established the first industrial process for pDNA purification using monolithic supports [16]. Here, we want to sum up recent studies describing monolithic purifications of the three major biomolecule classes: (1) viruses; (2) nucleic acids; and (3) proteins. We describe one success story for each biomolecule in more detail and compare it with conventional downstream strategies. We want to present the review as a yellow pages for bioprocess engineers, who face the challenge of purifying either of these biomolecules.

3.1. Virus Purification

Viruses can be used for the production of recombinant proteins and for gene therapy applications [40,41] and describe a major class of biomolecules in industry. Today, conventional virus purification includes centrifugation, filtration and chromatography, which either returns low yields (e.g., only 1% for ultracentrifugation [42]) or is time consuming and tedious. For several years, ion exchange monolithic supports have been extensively used for the purification of viruses. In 2013, Rupar et al. purified the potato virus Y (PVY) by conventional methods and by monoliths and compared both strategies (Figure 2; [31]). The authors used a CIM® QA (quaternary amine) monolith column and achieved product recovery and purity comparable to conventional purification methods involving ultracentrifugation. However, they could reduce the overall process time by more than half.
In another study, baculovirus from cell culture supernatant was successfully purified using the anion exchange monolithic column CIM® QA [30]. The authors were able to reduce the volume 82-fold, increase activity 51-fold and remove 99% of the contaminants. More successful applications of monolithic columns for the purification of viruses are summarized in Table 1.
Chromatography 02 00195 g002 1024
Figure 2. Schematic comparison of potato virus Y (PVY) purification between classical methods (A, B, D, E) and monolithic columns (A, B, C) [31].
Figure 2. Schematic comparison of potato virus Y (PVY) purification between classical methods (A, B, D, E) and monolithic columns (A, B, C) [31].
Chromatography 02 00195 g002
Table
Table 1. Applications of monolithic columns for purification and concentration of viruses.
Table 1. Applications of monolithic columns for purification and concentration of viruses.
VirusHostMonolithRef.
Bacteriophage T4E. coliCIM® QA[43]
Flavivirus particlesVero and baby hamster kidney (BHK) helper cells[44]
Adenovirus type 3 dodecahedric virus-like particles (VLP)High-Five cellsCIM® analytical column (CIMac®) QA[45]
Bacteriophage T7E. coliCustom made CIM® QA[46]
Mycobacteriophage D29M. smegmatisCIM® DEAE (diethylamine)[47]
Enterovirus 71Rhabdomyosarcoma cells[48]
Lentiviral vectorsHEK 293T cells[49]
293T/17 cellsCIM®-IDA(iminodiacetic acid )-Ni2+[50]
Bacteriophage VDX-10S. aureusCIM® QA and CIM® DEAE[51]
Bacteriophage PRD 1E.coli and S. enterica[52]
Burkholderia phage Phi208B. thailandensis[53]
Rubella virusHuman fetal lung fibroblast (MRC-5) cellsCIM® QA and CIM® SO3[54]
Influenza virus A and BVero cellsCIM® QA, CIM® DEAE and CIM® SO3[55]
VLPs (HBsAg)S. cerevisiaeCIM® C4 and CIM® OH[29]
Bacteriophage Phi6P. syringaeCIM® QA[56]
Potato virus YPlant tissue; N. tabacum and S. tuberosumCIM® QA[31]

3.2. Nucleic Acid Purification

Since the introduction of plasmid-based DNA (pDNA) therapeutics in the 1990s [57], they have been extensively used in medical diagnostics. In 2003, the first DNA vaccine for human therapy was approved [58]. These therapeutic applications require high amounts of highly pure pDNA. There is a variety of purification strategies available for the purification of pDNA using conventional methods, including tangential flow filtration (TFF) [59,60,61], membrane adsorption [62,63,64] and chromatography [65,66]. Monolithic columns with different functionalities have also been tested for the purification of pDNA. In the past few years, several studies described the successful grafting of a weak anion exchange monolithic column (CIM® DEAE) with different functionalities, such as hydrophobic and ion exchange moieties, to allow pDNA purification in only a single step [67,68,69]. This concept, called conjoint liquid chromatography (CLC), allows the formation of mixed mode monoliths. This provides a much faster, but still a very efficient alternative to the conventional multi-step procedure (Figure 3). The one-step strategy proved efficient for removal of over 99% of gDNA, RNA and host cell proteins and was able to achieve highly pure pDNA from cell culture. Theoretically, this strategy can easily be scaled up, giving a total amount of 15 g of pDNA, which can be purified with an 8-L column in only one single loading step [67]. However, monolithic columns have not only been employed for the purification of pDNA, but also for other nucleic acids (Table 2).
Chromatography 02 00195 g003 1024
Figure 3. Schematic comparison of pDNA purification between conventional methods (A, B, D, E) [65] and monolithic columns (A, B, C) [67]. AEX, anion exchange chromatography; HIC, hydrophobic interaction chromatography.
Figure 3. Schematic comparison of pDNA purification between conventional methods (A, B, D, E) [65] and monolithic columns (A, B, C) [67]. AEX, anion exchange chromatography; HIC, hydrophobic interaction chromatography.
Chromatography 02 00195 g003
Table
Table 2. Applications of monolithic columns for the purification of nucleic acids.
Table 2. Applications of monolithic columns for the purification of nucleic acids.
Nucleic acidHostMonolithRef.
PlasmidsE. coliCIM® DEAE[70]
pDNAE. coliCIM® DEAE bearing HIC and AEX groups[67]
pDNAE. coliCIM® DEAE, CIM® QA and CIM® C4 HLD (high ligand density)[69]
pDNA HPV-16 E6/E7E. coliCIMac®pDNA and Custom made CIM®-CDI (carboxydiimidazole) -arginine[71,72]
scpDNAE. coliCustom made CIM®-CDI-histamine amino acid derivative[73]
ocpDNAE. coliCIMac®pDNA[74]
pDNADH5-α mutantsCIM®-CDI-Cu2+[75]
pCCIFOS-25 (ds circular DNA)E.coliLaboratory made poly (glycidyl methacrylate - ethylene glycol dimethacrylate) column[76]
pre-miR-29R. sulfidophilumCustom made CIM®-CDI-agmatine[77]

3.3. Protein Purification

In conventional particle-based chromatography, different protein properties, like the isoelectric point and hydrophobicity, can be used to purify the product. Typical purification strategies comprise ion-exchange (IEX) and hydrophobic interaction (HIC) approaches, as well as the use of affinity tags. Since different raw materials and, thus, chemistries can be used for monoliths, the same purification principles can be applied there (Table 3). To mention only a few examples, ion-exchange monoliths have been successfully used for the purification of coagulation factors and recombinant proteins [78,79]; myoglobin, lysozyme [80] and bovine serum albumin [81] were purified by HIC monoliths; and affinity chromatography was employed for the purification of immunoglobulin G using a CIM® r-Protein A monolithic column [82,83]. More applications of monoliths for the purification of proteins are shown in Table 3.
Table
Table 3. Applications of monolithic columns for the purification of proteins.
Table 3. Applications of monolithic columns for the purification of proteins.
ProteinHostMonolithRef.
TNF-αE. coliCIM® DEAE and CIM®-IDA-Cu2+[84]
Horseradish peroxidaseP. pastorisCIM® DEAE[79]
β-glucosidasesP. etchellsiiCIM® DEAE and CIM® EDA (ethylendiamino)[85]
Host cell proteinsCHO cellsCIM® Protein-A HLD[86]
IgMIgM clone 84CIM® SO3, CIM® DEAE and CIM® CDI[87]
proteins extracted from blood group antigensanti-V5 hybridoma cell lineCustom made CIM® epoxy[88]
IgG1Hybridoma cellsCIM®-IDA with four different metal ions, namely Cu2+, Ni2+, Zn2+, Co2+[89]
Factor IXCHO cellsCIM® QA[78]
A prominent example for the use of a monolith for protein purification is the downstream process for Factor IX (FIX), which plays an important role in blood coagulation. Ribeiro et al. tested different particle-based and monolithic anion exchange resins for the purification of recombinant FIX (rFIX) from cell culture supernatant (Figure 4; [78]). Four different supports, namely monolith CIM® QA, Sartobind® Q, Q Sepharose® and Fractogel® TMAE (trimethylamino ethyl), were used for screening, and a pseudo-affinity elution with calcium chloride was developed. CIM® QA rendered the highest dynamic binding capacity in comparison to the other resins, namely 4.6 mg/mL of monolithic support. The authors conducted a design of experiments to optimize elution conditions and finally obtained a recovery yield of 83%, a purification factor of 304, 99.99% removal of DNA and 1,256-fold removal of host cell proteins in only one purification step. Upon up-scaling from a 1-mL to an 8-mL CIM® QA monolithic tube column, similar results were obtained [78].
Chromatography 02 00195 g004 1024
Figure 4. Schematic comparison of Factor IX (FIX) purification between conventional methods (A, B, D, E) [90] and monolithic columns (A, B, C) [78].
Figure 4. Schematic comparison of Factor IX (FIX) purification between conventional methods (A, B, D, E) [90] and monolithic columns (A, B, C) [78].
Chromatography 02 00195 g004

4. Commercially Available Monoliths

As shown above, monoliths are a powerful alternative to particle-based resins for the purification of biomolecules, and the first industrial processes employing monoliths have been launched. Thus, several providers offer monoliths of different chemistries, shapes and sizes. Polymethacrylate-based monolithic columns are currently produced and distributed by BIA separations (Ljubljana, Slovenia) under the trade name CIM® (convective interaction media), CIMac® (CIM analytical columns) and CIMmultus®. They also offer custom-made columns with different column chemistry to suit the needs of the end user. Dionex (CA, USA) also produces polymethacrylate monolithic columns under the trade name ProSwift®. Phenomenex (CA, USA) markets silica-based monolithic columns under the trade name Onyx®. Agilent technologies (CA, USA) markets poly-(glycidyl methacrylate-co ethylene dimethacrylate) monoliths, made by BIA separations, under the trade name Bio-monolith® [91]. Merck Millipore (MA, USA) has the trade name Chromolith® for marketing their silica-based monolithic columns. Bio-Rad (CA, USA) produces polymer-based monolithic columns under the trade name Uno®. A summary of commercially available monoliths, their underlying purification principle and respective distributors is given in Table 4.
Table
Table 4. Commercially available monolithic columns. Chromatography techniques: CEX, cation exchange; IEX, ion exchange; HILIC, hydrophilic interaction.
Table 4. Commercially available monolithic columns. Chromatography techniques: CEX, cation exchange; IEX, ion exchange; HILIC, hydrophilic interaction.
MonolithPrincipleManufacturer/SupplierRef.
CIM®, CIMmultus® and CIMac® QAAEXBIA separations[19]
CIM®, CIMmultus® and CIMac® DEAE
CIMac® pDNA
CIMac® Adeno
CIM® and CIMac® EDA
CIM®, CIMmultus® and CIMac® SO3CEX
CIM® and CIMmultus® C4 AHIC
CIM® and CIMmultus® OHHILIC
CIM® CDIAffinity
CIM® IDA
CIM® n-Protein A
CIM® r-Protein A
CIM® r-Protein G
CIM® r-Protein L
CIM® epoxy
ProSwift® RP monolith columnHICDionex[92]
ProSwift® IEX monolith columnIEX
ProSwift® ConA-1S affinity monolith columnAffinity
DNASwift® SAX-1S monolith columnAEX
PepSwift® monolith column
Onyx® monolithic C18 columnHICPhenomenex[93]
Onyx® monolithic C8 column
Onyx® monolithic HD-C18
Onyx® monolithic Si
Chromolith® RP-18e
Bio-Monolith® QAAEXAgilent technologies[94]
Bio-Monolith® DEAE
Bio-Monolith® SO3CEX
Bio-Monolith® Protein AAffinity
Chromolith® CapRod RP-18 endcapped 300-0.1 capillary columnHICMerck Millipore[95]
Chromolith® Phenyl 50-4.6 HPLC column
Chromolith® FastGradient RP-18 endcapped 50-2 HPLC column
Chromolith® FastGradient RP-18 endcapped 100-3 HPLC column
Chromolith® Flash RP-18 endcapped 25-2 HPLC column
Chromolith® Flash RP-18 endcapped 25-3 HPLC column
Chromolith® Prep RP-18 endcapped 100-25 column
UNO® Monolith Anion Exchange ColumnsAEXBio-Rad[96]
UNO® Monolith Cation Exchange ColumnsCEX
UNO® S1 ColumnIEX
UNO® S6 Column
UNO® S12 Column
UNO® Q1 Column
UNO® Q6 Column
UNO® Q12 Column

5. Concluding Remarks and Outlook

In terms of resolution and separation speed, monolithic columns outperform particle-based resins. Furthermore, scale-up does not affect the resolution of monolithic purification processes. It was shown that the dynamic binding capacity of monoliths, which is comparable to particle-based resins, actually increases with increasing product size. Furthermore, the possibility of using different raw materials, chemistries, pore sizes and grafting, which allows a high degree of freedom for the operator, causes an overwhelming interest in monoliths today. Our research group is currently conducting experiments to implement monolith technology as an impurity monitoring process analytical technology (PAT) tool across unit operations. In a similar approach, Smrekar et al. already implemented the monolith technology as a PAT tool to monitor a virus production process [97].
Another highly interesting approach was recently given by Fee et al., who used a 3D printer to manufacture monoliths with hexagonal channels from computer-aided design (CAD) models [98]. This allows more control in pore formation and distribution and might further boost the performance and applicability of monolith technology in the future.

Acknowledgments

The authors are grateful to BIA separations for providing monolithic columns and technical support.

Author Contributions

Vignesh Rajamanickam processed the literature and extracted relevant information. Vignesh Rajamanickam and Oliver Spadiut wrote the manuscript. Christoph Herwig and Oliver Spadiut supervised the work.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Center for Chemical Process Safety (CCPS). Guidelines for Process Safety in Bioprocess Manufacturing Facilities; Wiley: Hoboken, NJ, USA, 2010; p. 225. [Google Scholar]
  2. Kling, J. The Downstream Pinch—Upstream efficiencies, economic forces and changing technologies complicate separation and purification. BioProcess Int. 2014, 12, 1–9. [Google Scholar]
  3. Jungbauer, A.; Hahn, R. Polymethacrylate monoliths for preparative and industrial separation of biomolecular assemblies. J. Chromatogr. A 2008, 1184, 62–79. [Google Scholar] [CrossRef] [PubMed]
  4. Podgornik, A.; Savnik, A.; Jančar, J.; Krajnc, N.L. Design of monoliths through their mechanical properties. J. Chromatogr. A 2014, 1333, 9–17. [Google Scholar] [CrossRef] [PubMed]
  5. Podgornik, A.; Smrekar, V.; Krajnc, P.; Strancar, A. Estimation of methacrylate monolith binding capacity from pressure drop data. J. Chromatogr. A 2013, 1272, 50–55. [Google Scholar] [CrossRef] [PubMed]
  6. Stulík, K.; Pacáková, V.; Suchánková, J.; Coufal, P. Monolithic organic polymeric columns for capillary liquid chromatography and electrochromatography. J. Chromatogr. B. 2006, 841, 79–87. [Google Scholar] [CrossRef]
  7. Tennikova, T.B.; Bleha, M.; Švec, F. High-performance membrane chromatography of proteins, a novel method of protein separation. J. Chromatogr. A 2001, 555, 97–107. [Google Scholar] [CrossRef]
  8. Tennikova, T.B.; Svec, F.; Belenkii, B.G. High-Performance Membrane Chromatography. A Novel Method of Protein Separation. J. Liq. Chromatogr. 1990, 13, 63–70. [Google Scholar] [CrossRef]
  9. Belenkii, B.G.; Podkladenko, A.M. Peculiarities of zone migration and band broadening in gradient reversed-phase high-performance liquid chromatography of proteins with respect to membrane chromatography. J. Chromatogr. A 2001, 645, 1–15. [Google Scholar] [CrossRef]
  10. Svec, F.; Tennikova, T.B.; Deyl, Z. Monolithic Materials: Preparation, Properties and Applications; Elsevier B. V.: Amsterdam, The Netherlands, 2003; Volume 67, pp. 1–773. [Google Scholar]
  11. Hilder, E.F.; Svec, F.; Fréchet, J.M. Development and application of polymeric monolithic stationary phases for capillary electrochromatography. J. Chromatogr. A 2004, 1044, 3–22. [Google Scholar] [CrossRef] [PubMed]
  12. Svec, F. Recent developments in the field of monolithic stationary phases for capillary electrochromatography. J. Sep. Sci. 2005, 28, 729–745. [Google Scholar] [CrossRef] [PubMed]
  13. Dubinina, N.I.; Kurenbin, O.I.; Tennikova, T.B. Peculiarities of gradient ion-exchange high-performance liquid chromatography of proteins. J. Chromatogr. A 1996, 753, 217–225. [Google Scholar] [CrossRef] [PubMed]
  14. Guiochon, G. Monolithic columns in high-performance liquid chromatography. J. Chromatogr. A 2007, 1168, 101–168, discussion 100. [Google Scholar] [CrossRef] [PubMed]
  15. Siouffi, A.-M. Monolithic columns in high-performance liquid chromatography. J. Chromatogr. A 2006, 1126, 86–94. [Google Scholar] [CrossRef] [PubMed]
  16. Vlakh, E.G.; Tennikova, T.B. Applications of polymethacrylate-based monoliths in high-performance liquid chromatography. J. Chromatogr. A 2009, 1216, 2637–2650. [Google Scholar] [CrossRef] [PubMed]
  17. Jandera, P. Advances in the development of organic polymer monolithic columns and their applications in food analysis—A review. J. Chromatogr. A 2013, 1313, 37–53. [Google Scholar] [CrossRef] [PubMed]
  18. Pfaunmiller, E.L.; Paulemond, M.L.; Dupper, C.M.; Hage, D.S. Affinity monolith chromatography: A review of principles and recent analytical applications. Anal. Bioanal. Chem. 2013, 405, 2133–2145. [Google Scholar] [CrossRef] [PubMed]
  19. BIAseparations Bia Separations. Available online: http://www.biaseparations.com/default.asp (accessed on 6 December 2014).
  20. Sheehan, D. Physical Biochemistry: Principles and Applications, 2nd ed.; Wiley: Oxford, UK, 2009; p. 424. [Google Scholar]
  21. Strancar, A.; Podgornik, A.; Barut, M.; Necina, R. Short Monolithic Columns as Stationary Phases for Biochromatography. In Modern Advances in Chromatography; Springer-Verlag: Berlin Heidelberg, Germany, 2002; pp. 49–85. [Google Scholar]
  22. Vlakh, E.G.; Tennikova, T.B. Preparation of methacrylate monoliths. J. Sep. Sci. 2007, 30, 2801–2813. [Google Scholar] [CrossRef] [PubMed]
  23. Svec, F.; Frechet, J.M.J. Kinetic Control of Pore Formation in Macroporous Polymers. Formation of “Molded” Porous Materials with High Flow Characteristics for Separations or Catalysis. Chem. Mater. 1995, 7, 707–715. [Google Scholar] [CrossRef]
  24. Svec, F.; Frechet, J.M.J. Temperature, a simple and efficient tool for the control of pore size distribution in macroporous polymers. Macromolecules 1995, 28, 7580–7582. [Google Scholar] [CrossRef]
  25. Merhar, M.; Podgornik, A.; Barut, M.; Žigon, M.; Štrancar, A. Methacrylate monoliths prepared from various hydrophobic and hydrophilic monomers—Structural and chromatographic characteristics. J. Sep. Sci. 2003, 26, 322–330. [Google Scholar] [CrossRef]
  26. Barut, M.; Podgornik, A.; Urbas, L.; Gabor, B.; Brne, P.; Vidic, J.; Plevcak, S.; Strancar, A. Methacrylate-based short monolithic columns: Enabling tools for rapid and efficient analyses of biomolecules and nanoparticles. J. Sep. Sci. 2008, 31, 1867–1880. [Google Scholar] [CrossRef] [PubMed]
  27. Benčina, M.; Podgornik, A.; Štrancar, A. Characterization of methacrylate monoliths for purification of DNA molecules. J. Sep. Sci. 2004, 27, 801–810. [Google Scholar] [CrossRef] [PubMed]
  28. Krajnc, N.L.; Smrekar, F.; Cerne, J.; Raspor, P.; Modic, M.; Krgovic, D.; Strancar, A.; Podgornik, A. Purification of large plasmids with methacrylate monolithic columns. J. Sep. Sci. 2009, 32, 2682–2690. [Google Scholar] [CrossRef] [PubMed]
  29. Burden, C.S.; Jin, J.; Podgornik, A.; Bracewell, D.G. A monolith purification process for virus-like particles from yeast homogenate. J. Chromatogr. B. 2012, 880, 82–89. [Google Scholar] [CrossRef]
  30. Gerster, P.; Kopecky, E.-M.; Hammerschmidt, N.; Klausberger, M.; Krammer, F.; Grabherr, R.; Mersich, C.; Urbas, L.; Kramberger, P.; Paril, T.; et al. Purification of infective baculoviruses by monoliths. J. Chromatogr. A 2013, 1290, 36–45. [Google Scholar] [CrossRef] [PubMed]
  31. Rupar, M.; Ravnikar, M.; Tušek-Žnidarič, M.; Kramberger, P.; Glais, L.; Gutiérrez-Aguirre, I. Fast purification of the filamentous Potato virus Y using monolithic chromatographic supports. J. Chromatogr. A 2013, 1272, 33–40. [Google Scholar] [CrossRef] [PubMed]
  32. El Deeb, S.; Wätzig, H. Performance comparison between monolithic C18 and conventional C18 particle-packed columns in the liquid chromatographic determination of propranolol HCl. Turkish J. Chem. 2006, 30, 543–552. [Google Scholar]
  33. Szumski, M.; Buszewski, B. Preparation of Monolithic Capillary Chromatographic Columns Using Supercritical Fluid as a Porogen Solvent. Chromatographia 2014, 77, 1009–1017. [Google Scholar] [CrossRef] [PubMed]
  34. Ou, J.; Liu, Z.; Wang, H.; Lin, H.; Dong, J.; Zou, H. Recent development of hybrid organic-silica monolithic columns in CEC and capillary LC. Electrophoresis 2015, 36, 62–75. [Google Scholar] [CrossRef] [PubMed]
  35. Chen, M.-L.; Zheng, M.-M.; Feng, Y.-Q. Preparation of organic-inorganic hybrid silica monolith with octyl and sulfonic acid groups for capillary electrochromatograhpy and application in determination of theophylline and caffeine in beverage. J. Chromatogr. A 2010, 1217, 3547–3556. [Google Scholar] [CrossRef] [PubMed]
  36. Mayadunne, E.; El Rassi, Z. Facile preparation of octadecyl monoliths with incorporated carbon nanotubes and neutral monoliths with coated carbon nanotubes stationary phases for HPLC of small and large molecules by hydrophobic and π-π interactions. Talanta 2014, 129, 565–574. [Google Scholar] [CrossRef] [PubMed]
  37. Peyrin, E.; Caron, C.; Garrel, C.; Ravel, A.; Villet, A.; Grosset, C.; Favier, A. DNA migration regimes in hydrodynamic chromatography and slalom chromatography: Evidence for a transition. 2001, 55, 291–296. [Google Scholar] [CrossRef] [PubMed]
  38. Perrin, F.X.; Courderot, C.; Truong, T.; Pierre, J.; Thomassin, M.; Guinchard, C.; Guillaume, Y.C.; Nicod, L. Supercoiled circular DNA and protein retention in non-equilibrium chromatography Temperature and velocity dependence: Testimony of a transition. J. Chromatogr. A 2002, 950, 281–285. [Google Scholar] [CrossRef] [PubMed]
  39. Urban, J.; Jandera, P.; Schoenmakers, P. Preparation of monolithic columns with target mesopore-size distribution for potential use in size-exclusion chromatography. J. Chromatogr. A 2007, 1150, 279–289. [Google Scholar] [CrossRef] [PubMed]
  40. Hu, Y.-C. Baculovirus Vectors for Gene Therapy. Adv. Virus Res. 2006, 68, 287–320. [Google Scholar] [PubMed]
  41. Wang, C.-Y.; Li, F.; Yang, Y.; Guo, H.-Y.; Wu, C.-X.; Wang, S. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy. Cancer Res. 2006, 66, 5798–5806. [Google Scholar] [CrossRef] [PubMed]
  42. Chen, G.-Y.; Chen, C.-Y.; Chang, M.D.-T.; Matsuura, Y.; Hu, Y.-C. Concanavalin A affinity chromatography for efficient baculovirus purification. Biotechnol. Prog. 2009, 25, 1669–1677. [Google Scholar] [PubMed]
  43. Smrekar, F.; Ciringer, M.; Peterka, M.; Podgornik, A. Strancar, a Purification and concentration of bacteriophage T4 using monolithic chromatographic supports. J. Chromatogr. B 2008, 861, 177–180. [Google Scholar] [CrossRef]
  44. Mundle, S.T.; Giel-Moloney, M.; Kleanthous, H.; Pugachev, K.V.; Anderson, S.F. Preparation of pure, high titer, pseudoinfectious Flavivirus particles by hollow fiber tangential flow filtration and anion exchange chromatography. Vaccine 2014, in press. [Google Scholar]
  45. Urbas, L.; Jarc, B.L.; Barut, M.; Zochowska, M.; Chroboczek, J.; Pihlar, B.; Szolajska, E. Purification of recombinant adenovirus type 3 dodecahedric virus-like particles for biomedical applications using short monolithic columns. J. Chromatogr. A 2011, 1218, 2451–2459. [Google Scholar] [CrossRef] [PubMed]
  46. Smrekar, F.; Ciringer, M.; Strancar, A.; Podgornik, A. Characterisation of methacrylate monoliths for bacteriophage purification. J. Chromatogr. A 2011, 1218, 2438–2444. [Google Scholar] [CrossRef] [PubMed]
  47. Liu, K.; Wen, Z.; Li, N.; Yang, W.; Hu, L.; Wang, J.; Yin, Z.; Dong, X.; Li, J. Purification and concentration of mycobacteriophage D29 using monolithic chromatographic columns. J. Virol. Methods 2012, 186, 7–13. [Google Scholar] [CrossRef] [PubMed]
  48. Kattur Venkatachalam, A.R.; Szyporta, M.; Kiener, T.K.; Balraj, P.; Kwang, J. Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column. Virol. J. 2014, 11, 99. [Google Scholar] [CrossRef] [PubMed]
  49. Bandeira, V.; Peixoto, C.; Rodrigues, A.F.; Cruz, P.E.; Alves, P.M.; Coroadinha, A.S.; Carrondo, M.J.T. Downstream processing of lentiviral vectors: Releasing bottlenecks. Hum. Gene Ther. Methods 2012, 23, 255–263. [Google Scholar] [CrossRef] [PubMed]
  50. Cheeks, M.C.; Kamal, N.; Sorrell, A.; Darling, D.; Farzaneh, F.; Slater, N.K.H. Immobilized metal affinity chromatography of histidine-tagged lentiviral vectors using monolithic adsorbents. J. Chromatogr. A 2009, 1216, 2705–2711. [Google Scholar] [CrossRef] [PubMed]
  51. Kramberger, P.; Honour, R.C.; Herman, R.E.; Smrekar, F.; Peterka, M. Purification of the Staphylococcus aureus bacteriophages VDX-10 on methacrylate monoliths. J. Virol. Methods 2010, 166, 60–64. [Google Scholar] [CrossRef] [PubMed]
  52. Oksanen, H.M.; Domanska, A.; Bamford, D.H. Monolithic ion exchange chromatographic methods for virus purification. Virology 2012, 434, 271–277. [Google Scholar] [CrossRef] [PubMed]
  53. Adriaenssens, E.M.; Lehman, S.M.; Vandersteegen, K.; Vandenheuvel, D.; Philippe, D.L.; Cornelissen, A.; Clokie, M.R.J.; García, A.J.; De Proft, M.; Maes, M.; et al. CIM(®) monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles. Virology 2012, 434, 265–270. [Google Scholar] [CrossRef] [PubMed]
  54. Forcic, D.; Brgles, M.; Ivancic-Jelecki, J.; Santak, M.; Halassy, B.; Barut, M.; Jug, R.; Markušić, M.; Strancar, A. Concentration and purification of rubella virus using monolithic chromatographic support. J. Chromatogr. B 2011, 879, 981–986. [Google Scholar] [CrossRef]
  55. Banjac, M.; Roethl, E.; Gelhart, F.; Kramberger, P.; Jarc, B.L.; Jarc, M.; Strancar, A.; Muster, T.; Peterka, M. Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography. Vaccine 2014, 32, 2487–2492. [Google Scholar] [CrossRef] [PubMed]
  56. Romanovskaya, A.; Sarin, L.P.; Bamford, D.H.; Poranen, M.M. High-throughput purification of double-stranded RNA molecules using convective interaction media monolithic anion exchange columns. J. Chromatogr. A 2013, 1278, 54–60. [Google Scholar] [CrossRef] [PubMed]
  57. Wolff, J.A.; Malone, R.W.; Williams, P.; Chong, W.; Acsadi, G.; Jani, A.; Felgener, P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247, 1465–1468. [Google Scholar] [CrossRef] [PubMed]
  58. Patil, S.D.; Rhodes, D.G.; Burgess, D.J. DNA-based therapeutics and DNA delivery systems: A comprehensive review. AAPS J. 2005, 7, E61–E77. [Google Scholar] [CrossRef] [PubMed]
  59. Guerrero-Germán, P.; Prazeres, D.M.F.; Guzmán, R.; Montesinos-Cisneros, R.M.; Tejeda-Mansir, A. Purification of plasmid DNA using tangential flow filtration and tandem anion-exchange membrane chromatography. Bioprocess Biosyst. Eng. 2009, 32, 615–623. [Google Scholar] [CrossRef]
  60. Eon-Duval, A.; MacDuff, R.H.; Fisher, C.A.; Harris, M.J.; Brook, C. Removal of RNA impurities by tangential flow filtration in an RNase-free plasmid DNA purification process. Anal. Biochem. 2003, 316, 66–73. [Google Scholar] [CrossRef] [PubMed]
  61. Kahn, D.W.; Butler, M.D.; Cohen, D.L.; Gordon, M.; Kahn, J.W.; Winkler, M.E. Purification of plasmid DNA by tangential flow filtration. Biotechnol. Bioeng. 2000, 69, 101–106. [Google Scholar] [CrossRef] [PubMed]
  62. Zeng, X.; Ruckenstein, E. Membrane Chromatography: Preparation and Applications to Protein Separation. Biotechnol. Prog. 1999, 15, 1003–1019. [Google Scholar] [CrossRef] [PubMed]
  63. Kendall, D.; Lye, G.J.; Levy, M.S. Purification of plasmid DNA by an integrated operation comprising tangential flow filtration and nitrocellulose adsorption. Biotechnol. Bioeng. 2002, 79, 816–822. [Google Scholar] [CrossRef] [PubMed]
  64. Endres, H.N.; Johnson, J.A.; Ross, C.A.; Welp, J.K.; Etzel, M.R. Evaluation of an ion-exchange membrane for the purification of plasmid DNA. Biotechnol. Appl. Biochem. 2003, 37, 259–266. [Google Scholar] [CrossRef] [PubMed]
  65. Prazeres, D.M.F.; Schluep, T.; Cooney, C. Preparative purification of supercoiled plasmid DNA using anion-exchange chromatography. J. Chromatogr. A 1998, 806, 31–45. [Google Scholar] [CrossRef] [PubMed]
  66. Diogo, M.M.; Queiroz, J.A.; Monteiro, G.A.; Martins, S.A.; Ferreira, G.N.; Prazeres, D.M. Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography. Biotechnol. Bioeng. 2000, 68, 576–583. [Google Scholar] [CrossRef] [PubMed]
  67. Smrekar, V.; Smrekar, F.; Strancar, A.; Podgornik, A. Single step plasmid DNA purification using methacrylate monolith bearing combination of ion-exchange and hydrophobic groups. J. Chromatogr. A 2013, 1276, 58–64. [Google Scholar] [CrossRef] [PubMed]
  68. Peterka, M.; Glover, D.; Kramberger, P.; Banjac, M.; Podgornik, A.; Barut, M.; Štrancar, A. Short Monolithic Columns—An Enabling Technology for the Purification of Proteins, DNA, and Viruses. Bioprocess. J. 2005, 4, 79–84. [Google Scholar]
  69. Smrekar, F.; Podgornik, A.; Ciringer, M.; Kontrec, S.; Raspor, P.; Strancar, A.; Peterka, M. Preparation of pharmaceutical-grade plasmid DNA using methacrylate monolithic columns. Vaccine 2010, 28, 2039–2045. [Google Scholar] [CrossRef] [PubMed]
  70. Krajnc, N.L.; Smrekar, F.; Strancar, A.; Podgornik, A. Adsorption behavior of large plasmids on the anion-exchange methacrylate monolithic columns. J. Chromatogr. A 2011, 1218, 2413–2424. [Google Scholar] [CrossRef] [PubMed]
  71. Almeida, A.M.; Queiroz, J.A.; Sousa, F.; Sousa, A. Optimization of supercoiled HPV-16 E6/E7 plasmid DNA purification with arginine monolith using design of experiments. J. Chromatogr. B 2014, 978-979C, 145–150. [Google Scholar]
  72. Soares, A.; Queiroz, J.A.; Sousa, F.; Sousa, A. Purification of human papillomavirus 16 E6/E7 plasmid deoxyribonucleic acid-based vaccine using an arginine modified monolithic support. J. Chromatogr. A 2013, 1320, 72–79. [Google Scholar] [CrossRef] [PubMed]
  73. Sousa, A.; Almeida, A.M.; Černigoj, U.; Sousa, F.; Queiroz, J.A. Histamine monolith versatility to purify supercoiled plasmid deoxyribonucleic acid from Escherichia coli lysate. J. Chromatogr. A 2014, 1355, 125–133. [Google Scholar] [CrossRef] [PubMed]
  74. Gabor, B.; Černigoj, U.; Barut, M.; Štrancar, A. Reversible entrapment of plasmid deoxyribonucleic acid on different chromatographic supports. J. Chromatogr. A 2013, 1311, 106–114. [Google Scholar] [CrossRef] [PubMed]
  75. Shin, M.J.; Tan, L.; Jeong, M.H.; Kim, J.-H.; Choe, W.-S. Monolith-based immobilized metal affinity chromatography increases production efficiency for plasmid DNA purification. J. Chromatogr. A 2011, 1218, 5273–5278. [Google Scholar] [CrossRef] [PubMed]
  76. Ongkudon, C.M.; Pan, S.; Danquah, M.K. An innovative monolithic column preparation for the isolation of 25 kilo base pairs DNA. J. Chromatogr. A 2013, 1318, 156–162. [Google Scholar] [CrossRef] [PubMed]
  77. Pereira, P.; Sousa, A.; Queiroz, J.A.; Figueiras, A.; Sousa, F. Pharmaceutical-grade pre-miR-29 purification using an agmatine monolithic support. J. Chromatogr. A 2014, 1368, 173–182. [Google Scholar] [CrossRef] [PubMed]
  78. Ribeiro, D.A.; Passos, D.F.; Ferraz, H.C.; Castilho, L.R. Anion-exchange purification of recombinant factor IX from cell culture supernatant using different chromatography supports. J. Chromatogr. B 2013, 938, 111–118. [Google Scholar] [CrossRef]
  79. Krainer, F.W.; Pletzenauer, R.; Rossetti, L.; Herwig, C.; Glieder, A.; Spadiut, O. Purification and basic biochemical characterization of 19 recombinant plant peroxidase isoenzymes produced in Pichia pastoris. Protein Expr. Purif. 2014, 95, 104–112. [Google Scholar] [CrossRef] [PubMed]
  80. Hemström, P.; Nordborg, A.; Irgum, K.; Svec, F.; Fréchet, J.M.J. Polymer-based monolithic microcolumns for hydrophobic interaction chromatography of proteins. J. Sep. Sci. 2006, 29, 25–32. [Google Scholar] [CrossRef]
  81. Chen, M.-L.; Li, L.-M.; Yuan, B.-F.; Ma, Q.; Feng, Y.-Q. Preparation and characterization of methacrylate-based monolith for capillary hydrophilic interaction chromatography. J. Chromatogr. A 2012, 1230, 54–60. [Google Scholar] [CrossRef] [PubMed]
  82. Leblebici, P.; Leblebici, M.E.; Ferreira-da-Silva, F.; Rodrigues, A.E.; Pais, L.S. Separation of human immunoglobulin G subclasses on a protein A monolith column. J. Chromatogr. B 2014, 962, 89–93. [Google Scholar] [CrossRef]
  83. Nikolayenko, I.V.; Galkin, O.Y.; Grabchenko, N.I.; Spivak, M.Y. Preparation of highly purified human IgG, IgM, and IgA for immunization and immunoanalysis. Ukr. Bioorg. Acta 2005, 2, 3–11. [Google Scholar]
  84. Sushma, K.; Vijayalakshmi, M.A.; Krishnan, V.; Satheeshkumar, P.K. Cloning, expression, purification and characterization of a single chain variable fragment specific to tumor necrosis factor alpha in Escherichia coli. J. Biotechnol. 2010, 156, 238–244. [Google Scholar] [CrossRef] [PubMed]
  85. Gaonkar, R.K.; Mishra, S.; Vijayalakshmi, M.A. Purification of ß-glucosidases from Pichia etchellsii using CIM monolith columns. Appl. Biochem. Biotechnol. 2011, 164, 68–76. [Google Scholar] [CrossRef] [PubMed]
  86. Tscheliessnig, A.; Jungbauer, A. High-performance monolith affinity chromatography for fast quantitation of immunoglobulin G. J. Chromatogr. A 2009, 1216, 2676–2682. [Google Scholar] [CrossRef] [PubMed]
  87. Gan, H.T.; Lee, J.; Latiff, S.M.A.; Chuah, C.; Toh, P.; Lee, W.Y.; Gagnon, P. Characterization and removal of aggregates formed by nonspecific interaction of IgM monoclonal antibodies with chromatin catabolites during cell culture production. J. Chromatogr. A 2013, 1291, 33–40. [Google Scholar] [CrossRef] [PubMed]
  88. Mönster, A.; Hiller, O.; Grüger, D.; Blasczyk, R.; Kasper, C. Isolation and purification of blood group antigens using immuno-affinity chromatography on short monolithic columns. J. Chromatogr. A 2011, 1218, 706–710. [Google Scholar] [CrossRef] [PubMed]
  89. Rajak, P.; Vijayalakshmi, M.A.; Jayaprakash, N.S. Purification of monoclonal antibodies, IgG1, from cell culture supernatant by use of metal chelate convective interaction media monolithic columns. Biomed. Chromatogr. 2012, 26, 1488–1493. [Google Scholar] [CrossRef] [PubMed]
  90. Lindsay, M.; Gil, G.C.; Cadiz, A.; Velander, W.H.; Zhang, C.; Van Cott, K.E. Purification of recombinant DNA-derived factor IX produced in transgenic pig milk and fractionation of active and inactive subpopulations. J. Chromatogr. A 2004, 1026, 149–157. [Google Scholar] [CrossRef] [PubMed]
  91. Endicott, E. Agilent Technologies, BIA Separations GmbH Sign Agreement Giving Agilent Access to BIA Separations’ Bio-Monolithic Technology. Available online: http://www.agilent.com/about/newsroom/presrel/2008/29may-ca08038.html (accessed on 22 March 2015).
  92. Dionex. Available online: http://www.dionex.com/en-us/products/columns/bio/protein/proswift-iex/lp-73379.html (accessed on 15 April 2015).
  93. Onyx HPLC information. Available online: https://www.phenomenex.com/onyx (accessed on 6 December 2014).
  94. Bio-Monolith - Agilent. Available online: http://www.chem.agilent.com/en-US/products-services/Columns-Sample-Preparation/LC-LC-MS-Columns/BioHPLC/Bio-Monolith/Pages/default.aspx (accessed on 30 January 2015).
  95. Chromolith HPLC columns. Available online: http://www.merckmillipore.com/INTL/en/analytics-sample-prep/chromatography-for-analysis/analytical-hplc/chromolith-hplc-columns/Rk2b.qB.cMMAAAE_hPB3.Lxi,nav (accessed on 6 December 2014).
  96. Chromatography Columns - UNO monolithic columns. Available online: http://www.bio-rad.com/de-at/category/chromatography-columns (accessed on 30 January 2015).
  97. Smrekar, F.; Ciringer, M.; Jančar, J.; Raspor, P.; Strancar, A.; Podgornik, A. Optimization of lytic phage manufacturing in bioreactor using monolithic supports. J. Sep. Sci. 2011, 34, 2152–2158. [Google Scholar] [PubMed]
  98. Fee, C.; Nawada, S.; Dimartino, S. 3D printed porous media columns with fine control of column packing morphology. J. Chromatogr. A 2014, 1333, 18–24. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Rajamanickam, V.; Herwig, C.; Spadiut, O. Monoliths in Bioprocess Technology. Chromatography 2015, 2, 195-212. https://doi.org/10.3390/chromatography2020195

AMA Style

Rajamanickam V, Herwig C, Spadiut O. Monoliths in Bioprocess Technology. Chromatography. 2015; 2(2):195-212. https://doi.org/10.3390/chromatography2020195

Chicago/Turabian Style

Rajamanickam, Vignesh, Christoph Herwig, and Oliver Spadiut. 2015. "Monoliths in Bioprocess Technology" Chromatography 2, no. 2: 195-212. https://doi.org/10.3390/chromatography2020195

APA Style

Rajamanickam, V., Herwig, C., & Spadiut, O. (2015). Monoliths in Bioprocess Technology. Chromatography, 2(2), 195-212. https://doi.org/10.3390/chromatography2020195

Article Metrics

Back to TopTop